Biotech | November 22, 2024
Sartorius Stedim Biotech opens center for bioprocess innovation in USA
New research labs and process development services to enable next generation therapeutics
New research labs and process development services to enable next generation therapeutics
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Subscribe To Our Newsletter & Stay Updated
